UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update

Bagan, J; Scully, C; Sabater, V; Jimenez, Y; (2009) Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update. ORAL ONCOL , 45 (7) 551 - 554. 10.1016/j.oraloncology.2009.01.002.

Full text not available from this repository.

Abstract

Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a severe complication seen most frequently in patients on intravenous bisphosphonates treatment for malignant diseases. High potency bisphosphonates are generally implicated and risk factors also include dental extractions. Prevention is of paramount importance. Management is controversial but there is little evidence basis and the consensus is to be conservative. Recent advances in this area are summarised in this concise review. (C) 2009 Elsevier Ltd. All rights reserved.

Type:Article
Title:Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update
DOI:10.1016/j.oraloncology.2009.01.002
Keywords:Osteonecrosis, Bisphosphonates, Cancer, Jaws, MULTIPLE-MYELOMA, RISK-FACTORS, HYPERBARIC-OXYGEN, ZOLEDRONIC ACID, THERAPY, CANCER, PREVENTION, PREDICTION, MANAGEMENT, FREQUENCY
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Eastman Dental Institute

Archive Staff Only: edit this record